Clinical Trial Update: Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated Cetrotide-based regimens in women with polycystic ovary syndrome undergoing assisted reproductive technology; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• CETROTIDE (cetrorelix acetate)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Polycystic Ovarian Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-07-03